[Other] Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)

tarekcnn Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-27 16:55
Reward20points

journalㄩJournal of Clinical Oncology

AuthorsㄩInna M. Chen; Julia S. Johansen; Susann Theile; Jessica X. Hjaltelin; Sif I. Novitski; Sren Brunak; Jane P. Hasselby; Gro L. Willemoe; Torben Lorentzen; Kasper Madsen; Benny V. Jensen; Eva E. Wilken; Poul Geertsen; Claus Behrens; Christian Nolsoe; Kirstine L. Hermann; Inge Marie Svane; Dorte Nielsen

Published dateㄩ2022-9-20

DOIㄩ10.1200/jco.21.02511

PDF linkㄩhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02511

Article linkㄩhttps://doi.org/10.1200/jco.21.02511

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Intermediate member
  • post

  • reply

  • points

    390


Return to the list